Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression. | Genes Dis | 2024 | 37588203 | PubTator, text mining | PubMed |
| Cell death or survival: Insights into the role of mRNA translational control. | Semin Cell Dev Biol | 2024 | 37357122 | PubTator, text mining | PubMed |
| The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis. | Aging Dis | 2024 | 37307819 | PubTator, text mining | PubMed |
| Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development. | J Adv Res | 2024 | 37003532 | PubTator, text mining | PubMed |
| Dioxinodehydroeckol: A Potential Neuroprotective Marine Compound Identified by In Silico Screening for the Treatment and Management of Multiple Brain Disorders. | Mol Biotechnol | 2024 | 36513873 | PubTator, text mining | PubMed |
| m6A modification: a new avenue for anti-cancer therapy. | Life Med | 2023 | 39872957 | PubTator, text mining | PubMed |
| YTHDF1 in Tumor Cell Metabolism: An Updated Review. | Molecules | 2023 | 38202722 | PubTator, text mining | PubMed |
| The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors. | Molecules | 2023 | 38202657 | PubTator, text mining | PubMed |
| Regulation of m6A Methylome in Cancer: Mechanisms, Implications, and Therapeutic Strategies. | Cells | 2023 | 38201270 | PubTator, text mining | PubMed |
| m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy. | Front Immunol | 2023 | 38187373 | PubTator, text mining | PubMed |
| MrGPS: an m6A-related gene pair signature to predict the prognosis and immunological impact of glioma patients. | Brief Bioinform | 2023 | 38171932 | PubTator, text mining | PubMed |
| Investigating the prognostic value of m6A methylation-related genes in renal cell carcinoma patients. | Eur Rev Med Pharmacol Sci | 2023 | 38164857 | PubTator, text mining | PubMed |
| Immunotoxicity Evaluation of Trihalophenolic Disinfection By-Products in Mouse and Human Mononuclear Macrophage Systems: The Role of RNA Epitranscriptomic Modification in Mammalian Immunity. | Environ Health Perspect | 2023 | 38157273 | PubTator, text mining | PubMed |
| The current status and future of PD-L1 in liver cancer. | Front Immunol | 2023 | 38155974 | PubTator, text mining | PubMed |
| Potential role of N6-methyladenosine modification in the development of Parkinson's disease. | Front Cell Dev Biol | 2023 | 38155838 | PubTator, text mining | PubMed |
| The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma. | Front Oncol | 2023 | 38148842 | PubTator, text mining | PubMed |
| Epigenetic targeting of autophagy for cancer: DNA and RNA methylation. | Front Oncol | 2023 | 38148841 | PubTator, text mining | PubMed |
| Regulatory mechanisms of autophagy-related ncRNAs in bone metabolic diseases. | Front Pharmacol | 2023 | 38146458 | PubTator, text mining | PubMed |
| Decoding the role of m6A Regulators in identifying and characterizing molecular subtypes of rosacea. | Heliyon | 2023 | 38144308 | PubTator, text mining | PubMed |
| MeCP2-Induced Alternations of Transcript Levels and m6A Methylation in Human Retinal Pigment Epithelium Cells. | ACS Omega | 2023 | 38144074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=34